Abstract:Abstract Abstract #3098 [Background and purpose] Although glutathione S-transferase M1 (GSTM1) enzyme occupies a key position in biological detoxification processes by catalyzing the glutathione conjugation of carcinogens, GSTM1 gene is genetically deleted (referred as GSTM1-null or GSTM1-/-) in a high percentage of the Eurasian populations. Numerous studies have examined the association of GSTM1-/- with breast cancer yielding inconsistent results. In addition, few genetic variants in this gene have been explored. We set out to systematically evaluate the contributions of GSTM1 gene deletion/presence and common variants in GSTM1 to breast cancer, followed by functional studies.  [Methods and Results] In the present study, we show that GSTM1-/- does confer a weak increased risk of breast cancer compared with GSTM1-present genotype, being confirmed by a meta-analysis of combining 40 related studies with the current case-control study (921 cases vs. 711 controls) of Chinese population (overall odds ratio of 1.10, 95% confidence interval: 1.04-1.15, P<0.001). Unexpectedly, GSTM1 homozygous wild-type (+/+) is also associated with a risk of breast cancer compared with heterozygous (+/-) individuals on the basis of accurate classification using long-PCR-based assay. Furthermore, for the population with one allele of GSTM1 (GSTM1+/-) accounting for 30-50%, we genotype four common single nucleotide polymorphisms (SNPs) spanning GSTM1 gene and identify a functional variant g.-498C>G in the putative promoter region associated with breast cancer risk. It displays that minor -498G allele is significantly more frequent in breast cancer controls than in cases (odds ratio of 0.51, 95% confidence interval: 0.30-0.86, P=0.012). This allele also leads to significantly reduced promoter activity compared to the major -498C allele. Further studies reveal the -498G can modify AP-2 binding site and decrease GSTM1 transcription. Among the three AP-2 isoforms, AP-2α provides the predominant regulation effect on this SNP.  [Conclusions] These results indicate that the effect of GSTM1 genotypes conferring to breast cancer susceptibility is not dosage-dependent as taken for grant previously. GSTM1 has a two-sided role in breast cancer susceptibility; too high or too low expression of GSTM1 is not beneficial. We recommend that the complicated genetic predisposition of GSTM1 be considered when predicting breast cancer susceptibility using single or a panel of genetic variants. Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 3098.

Down Regulation in Glutathione S-Transferase Stimulate Oxidative Stress and Genetic Susceptibility of Human Breast Cancer

Glutathione S-Transferase T1 Null Genotype is Associated with Susceptibility to Inflammatory Bowel Disease

Glutathione S-transferase M1 polymorphism and the risk on colorectal cancer: a multilevel meta regression]

Associations Between Genetic Polymorphisms of Glutathione S-transferase M1 and T1,smoking and Susceptibility to Colorectal Cancer:A Case-Control Study

Glutathione S-transferase M1, T1, and P1 polymorphisms and risk of glioma: a meta-analysis

Glutathione S-transferase T1 Polymorphism is Associated with Breast Cancer Susceptibility

The New Understanding Of Two-Sided Role Of Glutathione S-Transferase M1 In Breast Cancer Susceptibility

[Association Between Genetic Polymorphisms of Metabolic Enzymes and Susceptibility of Colorectal Cancer].

Relationship between metabolic enzyme polymorphism and colorectal cancer.

Genetic Polymorphisms in Glutathione S-Transferase (GST) Gene and Their Correlation with Toxicity of Chemotherapy in Breast Cancer Patients

Glutathione S-Transferase M1 Polymorphism and Breast Cancer Susceptibility: A Meta-Analysis Involving 46,281 Subjects

Genetic Polymorphisms in Glutathione-S-Transferase Genes (gstm1, Gstt1, Gstp1) and Survival after Chemotherapy for Invasive Breast Carcinoma

Association of Glutathione S-transferase T1, M1, and P1 Polymorphisms in the Breast Cancer Risk: a Meta-Analysis

Interaction Between Glutathione S‐transferase M1‐null/present Polymorphism and Adjuvant Chemotherapy Influences the Survival of Breast Cancer

Association Of The Glutathione S-Transferase M1, T1 Polymorphisms With Cancer: Evidence From A Meta-Analysis

Glutathione S-transferase P1 rs1695 A>G polymorphism and breast cancer risk: evidence from a meta-analysis.

The Multifaceted Role of Glutathione S-Transferases in Health and Disease

Single Nucleotide Polymorphism Of Pi-Class Glutathione S-Transferase And Susceptibility To Endometrial Carcinoma

Quantitative assessment of the association between glutathione S-transferase M1 polymorphism and the risk of developing nasopharyngeal cancer

Genetic Variants in Gstm3 Gene Within Gstm4-Gstm2-Gstm1-Gstm5-Gstm3 Cluster Influence Breast Cancer Susceptibility Depending on Gstm1

Genetic Polymorphisms Of Glutathione S-Transferase Genes Gstm1, Gstt1 And Risk Of Hepatocellular Carcinoma